Ranbaxy Laboratories Limited (RANBAXY) - Pharmaceuticals & Hea...

Today, the United States government brought to a conclusion an eight-year criminal and civil investigation of Ranbaxy Laboratories Limited, India's largest generic drug company, and Ranbaxy, Inc., Ranbaxy Pharmaceuticals, Inc., Ranbaxy Laboratories, ...

/PRNewswire-USNewswire/ -- Stein Mitchell Muse & Cipollone LLP announced today that Ranbaxy Laboratories Limited ("Ranbaxy"), India 's largest generic drug manufacturer, has agreed to pay $500 million to the United States and individual ...

Ranbaxy Laboratories Ltd has announced the financial results for the quarter ended March 31, 2013.The Company has posted a net profit of Rs. 701.47 million for the quarter ended March 31, 2013 as compared to Rs. 8272.31 million for the quarter ended ...

One should hold Ranbaxy Laboratories in the portfolio and from current level it can go to Rs 475, says Atul Badkar, VP - Institutional Equities - Derivatives Desk at Edelweiss Securities.

Shares of Ranbaxy Laboratories recovered from early losses and settled nearly 4 per cent higher on hopes that settlement of its long lawsuit in the US would be positive for drug maker the in the long term. The stock opened weak on the BSE and fell ...

Ranbaxy Laboratories announced conclusion of previously disclosed investigation by US Department of Justice.

Our home-grown pharma giant Ranbaxy Laboratories has been slapped a $500 million fine in the US for selling adulterated drugs. The three drugs in question were manufactured at two plants in India. The

After making a weak opening, shares of the company further tanked 4.22 per cent to

MUMBAI: Shares of Ranbaxy Laboratories, after a knee-jerk reaction in opening trade, pared intraday losses and moved in the positive terrain as the company has already made provision of $500 million to the settle criminal and civil lawsuit, say ...